PMID- 24900107
OWN - NLM
STAT- PubMed-not-MEDLINE
DCOM- 20140606
LR  - 20211021
IS  - 1869-3474 (Print)
IS  - 1869-3482 (Electronic)
IS  - 1869-3474 (Linking)
VI  - 47
IP  - 3
DP  - 2013 Sep
TI  - Myocardial Fibrosis in Hypertrophic Cardiomyopathy Demonstrated by Integrated 
      Cardiac F-18 FDG PET/MR.
PG  - 196-200
LID - 10.1007/s13139-013-0201-0 [doi]
AB  - Hypertrophic cardiomyopathy (HCM) is a common condition defined as a diffuse or 
      segmental left ventricular (LV) hypertrophy with a nondilated and hyperdynamic 
      chamber as well as cardiac arrhythmias. Cardiac MR (CMR) imaging is a key 
      modality for evaluation of HCM. In addition to the assessment of LV wall 
      thickness, LV function and aortic flow, CMR is capable of estimation of late 
      gadolinium enhancement (LGE) in affected myocardium which has been shown to have 
      a direct correlation with incidence and severity of arrhythmias in HCM. In 
      patients with HCM, LGE on CMR is presumed to represent intramyocardial fibrosis. 
      Meanwhile, F-18 FDG myocardial PET has been sporadically studied in HCM, mostly 
      for evaluation of the metabolic status of a hypertrophic myocardial segment, 
      especially after interventions or to demonstrate partial myocardial fibrosis. We 
      presented here the case of a 25-year-old male patient referred for simultaneous 
      F-18 FDG cardiac PET/MR for the evaluation of septal hypertrophy. The PET/MR 
      revealed myocardial fibrosis in the septum associated with FDG-defect and LGE.
FAU - Kong, Eun-Jung
AU  - Kong EJ
AD  - Department of Nuclear Medicine, Yeungnam University, College of Medicine, Daegu 
      Hyunchungro 170, South Korea.
FAU - Lee, Sang-Hee
AU  - Lee SH
AD  - Department of Internal Medicine, Yeungnam University, College of Medicine, Daegu 
      Hyunchungro 170, South Korea.
FAU - Cho, Ihn-Ho
AU  - Cho IH
AD  - Department of Nuclear Medicine, Yeungnam University, College of Medicine, Daegu 
      Hyunchungro 170, South Korea.
LA  - eng
PT  - Journal Article
DEP - 20130410
PL  - Germany
TA  - Nucl Med Mol Imaging
JT  - Nuclear medicine and molecular imaging
JID - 101530478
PMC - PMC4035195
OTO - NOTNLM
OT  - Cardiovascular magnetic resonance
OT  - FDG
OT  - Fibrosis
OT  - Hypertrophic cardiomyopathy
OT  - PET/MRI
EDAT- 2014/06/06 06:00
MHDA- 2014/06/06 06:01
PMCR- 2014/09/01
CRDT- 2014/06/06 06:00
PHST- 2013/01/13 00:00 [received]
PHST- 2013/02/19 00:00 [revised]
PHST- 2013/03/13 00:00 [accepted]
PHST- 2014/06/06 06:00 [entrez]
PHST- 2014/06/06 06:00 [pubmed]
PHST- 2014/06/06 06:01 [medline]
PHST- 2014/09/01 00:00 [pmc-release]
AID - 201 [pii]
AID - 10.1007/s13139-013-0201-0 [doi]
PST - ppublish
SO  - Nucl Med Mol Imaging. 2013 Sep;47(3):196-200. doi: 10.1007/s13139-013-0201-0. 
      Epub 2013 Apr 10.